Hormonal regulation of the Grb14 signal modulator and its role in cell cycle progression of MCF-7 human breast cancer cells

Journal of Cellular Physiology

Volumn 203, Issue 1, 2005, Pages 85-93

  Kairouz, Rania ^a   Parmar, Jayamala ^a   Lyons, Ruth J ^a   Swarbrick, Alexander ^a   Musgrove, Elizabeth A ^a   Daly, Roger J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; INSULIN; PROTEIN GRB14; PROTEIN SH2; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HORMONAL REGULATION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; ESTRADIOL; ESTROGEN ANTAGONISTS; FEEDBACK, BIOCHEMICAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTEINS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 14744278420     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20199     Document Type: Article

References (55)

1. Altucci L, Addeo R, Cicatiello L, Dauvois S, Parker MG, Truss M, Beato M, Sica V, Bresciani F, Weisz A. 1996. 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene 12(11):2315-2324.
2. Bereziat V, Kasus-Jacobi A, Perdereau D, Cariou B, Girard J, Burnol A. 2002. Inhibition of insulin receptor catalytic activity by the molecular adaptor Grb14. J Biol Chem 277(7):4845-4852.
3. Buckley MF, Sweeney KJE, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CKW, Musgrove EA, Sutherland RL. 1993. Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127-2133.
4. Caristi S, Galera JL, Matarese F, Imai M, Caporali S, Cancemi M, Altucci L, Cicatiello L, Teti D, Bresciani F, Weisz A. 2001. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G1 progression in human breast cancer cells. Cancer Res 61:6360-6366.
5. Clarke R. 2000. Introduction and overview: Sex steroids in the mammary gland. J Mammary Gland Biol Neoplasia 5:245-250.
6. Cooney GJ, Lyons RJ, Crew AJ, Jensen TE, Molero JC, Mitchell CJ, Biden TJ, Ormandy CJ, James DE, Daly RJ. 2004. Improved glucose homeostasis and enhanced insulin signalling in Grb14-deficient mice. EMBO J 23:582-593.
7. Daly R. 1998. The Grb7 family of signalling proteins. Cell Signal 10:613-618.
8. Daly RJ, Sanderson GM, Janes PJ, Sutherland RL. 1996. Cloning and characterization of Grb14, a novel member of the Grb7 gene family. J Biol Chem 271:12502-12510.
9. Frantz J, Giorgetti-Peraldi S, Ottinger E, Shoelson S. 1997. Human GRB-IRb/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains. J Biol Chem 272:2659-2667.
10. Gross JM, Douglas Y. 2002. How does the estrogen receptor work? Breast Cancer Res 4:62-64.
11. Grunt TW, Saceda M, Martin MB, Lupu R, Dittrich E, Krupitza G, Harant H, Huber H, Dittrich C. 1995. Bidirectional interactions between the estrogen receptor and the c-erbB-2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells. Int J Cancer 63:560-567.
12. Han DC, Guan J-L. 1999. Association of focal adhesion kinase with Grb7 and its role in cell migration. J Biol Chem 274(34):24425-24430.
13. Han DC, Shen T-L, Guan J-L. 2001. The Grb7 family proteins: Structure, interactions with other signaling molecules and potential cellular functions. Oncogene 20:6315-6321.
14. He W, Rose D, Olefsky J, Gustafson T. 1998. Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains. J Biol Chem 273:6860-6867.
15. Hemming R, Agatep R, Badiani K, Wyant K, Arthur G, Gietz RD, Triggs-Raine B. 2001. Human growth factor bound 14 binds the activated insulin receptor and alters the insulin-stimulated tyrosine phosphorylation levels of multiple proteins. Biochem Cell Biol 79:21-32.
16. Huynh H, Nickerson T, Pollak M, Yang X. 1996a. Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780. Clin Cancer Res 2(12):2037-2042.
17. Huynh H, Yang X, Pollak M. 1996b. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J Biol Chem 271(2):1016-1021.
18. Huynh H, Yang X-F, Pollak M. 1996c. A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780. Cell Growth Differ 7:1501-1506.
19. Janes PW, Daly RJ, deFazio A, Sutherland RL. 1994. Activation of the Ras signalling pathway in human breast cancer cell lines overexpressing erbB-2. Oncogene 9:3601-3608.
20. Kahlert S, Nuedling S, Eickels MV, Vetter H, Meyer R, Grohe C. 2000. Estrogen receptor a rapidly activates the IGF-1 receptor pathway. J Biol Chem 275(24):18447-18453.
21. Kasus-Jacobi A, Perdereau D, Auzan C, Clauser E, Van Obberghen E, Mauvais-Jarvis F, Girard J, Burnol A. 1998. Identification of the rat adapter Grb14 as an inhibitor of insulin actions. J Biol Chem 273:26026-26035.
22. Kasus-Jacobi A, Bereziat V, Perdereau D, Girard J, Burnol A. 2000. Evidence for an interaction between the insulin receptor and Grb7. A role for two of its binding domains, PIR and SH2. Oncogene 19(16):2052-2059.
23. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P. 1995. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494.
24. Krebs DL, Hilton DJ. 2001. SOCS proteins: Negative regulators of cytokine signalling. Stem Cells 19:378-387.
25. Kurokawa H, Lenferink AEG, Simpson JF, Pisacane PI, Sliwkowski MX, Forbes JT, Arteaga CL. 2000. Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. Cancer Res 60:5887-5894.
26. Lai A, Sarcevic B, Prall OWJ, Sutherland RL. 2001. Insulin/insulin-like growth factor-1 and estrogen cooperate to stimulate cyclin E-cdk2 activation and cell cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21 WAF1/cip1. J Biol Chem 276(28):25823-25833.
27. Lee AV, Weng CN, Jackson JG, Yee D. 1997. Activation of estrogen receptor-mediated gene transcription by IGF-1 in human breast cancer cells. J Endocrinol 152:39-47.
28. Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D. 1999. Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol 13:787-796.
29. Liu F, Roth RA. 1995. Grb-IR: A SH2-domain-containing protein that binds to the insulin receptor and inhibits its function. Proc Natl Acad Sci USA 92:10287-10291.
30. Mathieu M, Vignon F, Capony F, Rochefort H. 1991. Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: A receptor saturation mechanism to increase the secretion of lysosomal proenzymes. Mol Endocrinol 5:815-822.
31. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F. 1996. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15:1292-1300.
32. Molloy CA, May FEB, Westley BR. 2000. Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line. J Biol Chem 275(17):12565-12571.
33. Morrione A, Valentinis B, Resnicoff M, Xu S, Baserga R. 1997. The role of mGrb10a in insulin-like growth factor I-mediated growth. J Biol Chem 272:26382-26387.
34. Mounier C, Lavoie L, Dumas V, Mohammad-Ali K, Wu J, Nantel A, Bergeron JJM, Thomas DY, Posner BI. 2001. Specific inhibition by hGRB10 z of insulin-induced glycogen synthase activation: Evidence for a novel signaling pathway. Mol Cell Endocrinol 173:15-27.
35. Musgrove EA, Hunter LK, Lee CSL, Swarbrick A, Hui R, Sutherland R. 2001. Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27kip1 association with cyclin-E-cdk2. J Biol Chem 276(50):47675-47683.
36. Patrone C, Ma ZQ, Pollio G, Agrati P, Parker MG, Maggi A. 1996. Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells. Mol Endocrinol 10:499-507.
37. Perks CM, Holly JMP. 2000. Insulin-like growth factor binding proteins (IGFBPs) in breast cancer. J Mammary Gland Biol Neoplasia 5(1):75-84.
38. Prall OWJ, Sarcevic B, Musgrove EA, Watts CKW, Sutherland RL. 1997. Estrogen-induced activation of cdk4 and cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J Biol Chem 272:10882-10894.
39. Prall OWJ, Sarcevic B, Musgrove EA, Watts CKW, Sutherland RL. 1998. c-myc or cyclin D1 mimics estrogen effects on cyclin E-cdk2 activation and cell cycle reentry. Mol Cell Biol 18:4499-4508.
40. Reilly J, Mickey G, Maher P. 2000. Association of fibroblast growth factor receptor 1 with the adaptor protein Grb14. Characterization of a new receptor binding partner. J Biol Chem 275(11):7771-7778.
41. Rice KM, Turnbow MA, Garner CW. 1993. Insulin stimulates the degradation of IRS-1 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 190:961-967.
42. Saito H, Morita Y, Fujimoto M, Narazaki M, Naka T, Kishimoto T. 2000. IFN regulatory factor-1-mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 gene promoter by IFN-g. J Immunol 164:5833-5843.
43. Salerno M, Sisci D, Mauro L, Guvakova MA, Ando S, Surmacz E. 1999. Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells. Int J Cancer 81:299-304.
44. Schlessinger J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103:211-225.
45. Starr R, Willson TA, Viney EM, Murray LJL, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917-921.
46. Stein E, Gustafson T, Hubbard S. 2001. The BPS domain of Grb10 inhibits the catalytic activity of the insulin and IGF1 receptors. FEBS Lett 493:106-111.
47. Stewart AJ, Johnson MD, May FEB, Westley BR. 1990. Role of insulin like growth factors and the type I insulin like growth factor receptor in the estrogen stimulated proliferation of human breast cancer cells. J Biol Chem 265:21172-21178.
48. Stewart A, Westley B, May F. 1992. Modulation of the proliferative response of breast cancer cells to growth factors by estrogen. Brit J Cancer 66:640-648.
49. Stoica A, Saceda M, Fakhro A, Joyner M, Martin MB. 2000. Role of insulin-like growth factor-1 in regulating estrogen receptor-a gene expression. J Cell Biochem 76:605-614.
50. Sun XJ. 1992. Expression and function of IRS-1 in insulin signal transmission. J Biol Chem 267(31):22662-22672.
51. Tanaka S, Mori M, Akiyoshi T, Tanaka Y, Mafune K, Wands JR, Sugimachi K. 1998. A novel variant of human Grb7 is associated with invasive esophageal carcinoma. J Clin Invest 102(4):821-827.
52. Wiseman LR, Johnson MD, Wakeling AE, Lykkesfeldt AE, May FE, Westley BR. 1993. Type 1 IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells. Eur J Cancer 29A:2256-2264.
53. Wojcik J, Girault J, Labesse G, Chomilier J, Mornon J, Callebaut I. 1999. Sequence analysis identifies a ras-associating (RA)-like domain in the N-termini of band 4.1/JEF domains and in the Grb7/10/14 adapter family. Biochem Biophys Res Commun 259(1):113-120.
54. Yee D, Lee AV. 2000. Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J Mammary Gland Biol Neoplasia 5(1):107-115.
55. Yee D, Cullen JK, Paik S, Perdue JF, Hampton B, Schwartz A, Lippman ME, Rosen N. 1988. Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 48:6691-6696.